22nd Jan 2024 The effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes: a plain language summary
16th Nov 2023 Plain language summary of the EMPEROR-Preserved : drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction
15th Nov 2023 A plain language summary of the EMPEROR-Reduced study: drug treatment with empagliflozin lowered risk for hospitalization in people with heart failure with reduced ejection fraction
11th Apr 2023 Plain Language Summary: long-term survival in people being treated with tafamidis for transthyretin amyloid cardiomyopathy